Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Treatment Options in Neurology
|
April 15, 2009
Clinically isolated syndrome and multiple sclerosis: rethinking the arsenal
Krupa Pandey, Fred D Lublin
Archives of Physical Medicine and Rehabilitation
|
September 28, 2020
Vision Problems in Multiple Sclerosis
Silvana L Costa, Krupa Pandey, Jennifer Hrdina, et al.
AIMS Neuroscience
|
July 28, 2025
Interleukin-6 targeting antibodies for the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): A review of current literature
Siddarth R Ganesh, Orion Yedidia, Krupa Pandey, et al.
Multiple Sclerosis and Related Disorders
|
September 23, 2019
Rituximab-induced serum sickness in multiple sclerosis patients
Andrew B Wolf, Lana Zhovtis Ryerson, Krupa Pandey, et al.
Therapeutic Advances in Neurological Disorders
|
November 2, 2016
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis
Lana Zhovtis Ryerson, Rivka Green, Gladyne Confident, et al.
Western Journal of Nursing Research
|
August 4, 2020
Improving Sleep among Adults with Multiple Sclerosis using Mindfulness plus Sleep Education
Rebecca A Lorenz, Samantha Auerbach, Patricia Nisbet, et al.
Brain and Cognition
|
August 10, 2025
Aerobic walking exercise training boosts thalamic connectivity in MS patients with cognitive processing speed impairment
Brian M Sandroff, Robert W Motl, Glenn R Wylie, et al.
Multiple Sclerosis and Related Disorders
|
September 5, 2025
Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
Haley Nauman, Grace E Wells, Olesya Iosipchuk, et al.
Journal of Neuroimmunology
|
March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Treatment Options in Neurology
|
April 15, 2009
Clinically isolated syndrome and multiple sclerosis: rethinking the arsenal
Krupa Pandey, Fred D Lublin
Archives of Physical Medicine and Rehabilitation
|
September 28, 2020
Vision Problems in Multiple Sclerosis
Silvana L Costa, Krupa Pandey, Jennifer Hrdina, et al.
AIMS Neuroscience
|
July 28, 2025
Interleukin-6 targeting antibodies for the treatment of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): A review of current literature
Siddarth R Ganesh, Orion Yedidia, Krupa Pandey, et al.
Multiple Sclerosis and Related Disorders
|
September 23, 2019
Rituximab-induced serum sickness in multiple sclerosis patients
Andrew B Wolf, Lana Zhovtis Ryerson, Krupa Pandey, et al.
Therapeutic Advances in Neurological Disorders
|
November 2, 2016
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis
Lana Zhovtis Ryerson, Rivka Green, Gladyne Confident, et al.
Western Journal of Nursing Research
|
August 4, 2020
Improving Sleep among Adults with Multiple Sclerosis using Mindfulness plus Sleep Education
Rebecca A Lorenz, Samantha Auerbach, Patricia Nisbet, et al.
Brain and Cognition
|
August 10, 2025
Aerobic walking exercise training boosts thalamic connectivity in MS patients with cognitive processing speed impairment
Brian M Sandroff, Robert W Motl, Glenn R Wylie, et al.
Multiple Sclerosis and Related Disorders
|
September 5, 2025
Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
Haley Nauman, Grace E Wells, Olesya Iosipchuk, et al.
Journal of Neuroimmunology
|
March 25, 2025
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 12, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice
Hesham Abboud, Brian Steingo, Diana Vargas, et al.
Page
of 1